The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma

Jody E. Hooper, Terry K. Morgan, Markus Grompe, Brett C. Sheppard, Megan L. Troxell, Christopher L. Corless, Philip R. Streeter

Research output: Contribution to journalArticlepeer-review

14 Scopus citations

Fingerprint

Dive into the research topics of 'The novel monoclonal antibody HPC2 and N-cadherin distinguish pancreatic ductal adenocarcinoma from cholangiocarcinoma'. Together they form a unique fingerprint.

Medicine & Life Sciences